These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7965774)

  • 1. Pharmacologic evidence that spinal muscarinic analgesia is mediated by an L-arginine/nitric oxide/cyclic GMP cascade in rats.
    Iwamoto ET; Marion L
    J Pharmacol Exp Ther; 1994 Nov; 271(2):601-8. PubMed ID: 7965774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological evidence that nitric oxide mediates the antinociception produced by muscarinic agonists in the rostral ventral medulla of rats.
    Iwamoto ET; Marion L
    J Pharmacol Exp Ther; 1994 May; 269(2):699-708. PubMed ID: 7514222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide/cyclic guanosine monophosphate system in the spinal cord differentially modulates intracerebroventricularly administered morphine- and beta-endorphin-induced antinociception in the mouse.
    Xu JY; Tseng LF
    J Pharmacol Exp Ther; 1995 Jul; 274(1):8-16. PubMed ID: 7616452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats.
    Iwamoto ET; Marion L
    J Pharmacol Exp Ther; 1993 Jul; 266(1):329-38. PubMed ID: 8101218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance P N-terminal metabolites and nitric oxide mediate capsaicin-induced antinociception in the adult mouse.
    Kreeger JS; Kitto KF; Larson AA
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1281-5. PubMed ID: 7527854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nitric oxide/cyclic GMP system at the supraspinal site is involved in the development of acute morphine antinociceptive tolerance.
    Xu JY; Hill KP; Bidlack JM
    J Pharmacol Exp Ther; 1998 Jan; 284(1):196-201. PubMed ID: 9435178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nitric oxide/cyclic GMP in i.c.v. administered beta-endorphin- and (+)-cis-dioxolane-induced antinociception in the mouse.
    Xu JY; Tseng LF
    Eur J Pharmacol; 1994 Sep; 262(3):223-31. PubMed ID: 7813587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bed.
    McCulloch AI; Bottrill FE; Randall MD; Hiley CR
    Br J Pharmacol; 1997 Apr; 120(8):1431-8. PubMed ID: 9113362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible involvement of the spinal nitric oxide/cGMP pathway in vincristine-induced painful neuropathy in mice.
    Kamei J; Tamura N; Saitoh A
    Pain; 2005 Sep; 117(1-2):112-20. PubMed ID: 16098672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
    Machelska H; Labuz D; Przewłocki R; Przewłocka B
    J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecally injected morphine inhibits inflammatory paw edema: the involvement of nitric oxide and cyclic-guanosine monophosphate.
    Brock SC; Tonussi CR
    Anesth Analg; 2008 Mar; 106(3):965-71, table of contents. PubMed ID: 18292447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociception after nicotine administration into the mesopontine tegmentum of rats: evidence for muscarinic actions.
    Iwamoto ET
    J Pharmacol Exp Ther; 1989 Nov; 251(2):412-21. PubMed ID: 2810106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
    Stewart PE; Hammond DL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple spinal mediators in parenteral nicotine-induced antinociception.
    Rogers DT; Iwamoto ET
    J Pharmacol Exp Ther; 1993 Oct; 267(1):341-9. PubMed ID: 7901397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of intrathecally and intracerebroventricularly administered nitric oxide donors on noxious mechanical and thermal stimulation.
    Machelska H; Przewłocki R; Radomski MW; Przewłocka B
    Pol J Pharmacol; 1998; 50(6):407-15. PubMed ID: 10385923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of nitric oxide synthesis antagonize nitrous oxide antinociception in mice and rats.
    McDonald CE; Gagnon MJ; Ellenberger EA; Hodges BL; Ream JK; Tousman SA; Quock RM
    J Pharmacol Exp Ther; 1994 May; 269(2):601-8. PubMed ID: 8182526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of nitric oxide/cyclic GMP/K(+) channel pathways in the antinociceptive effect caused by 2,3-bis(mesitylseleno)propenol.
    Jesse CR; Savegnago L; Nogueira CW
    Life Sci; 2007 Dec; 81(25-26):1694-702. PubMed ID: 18031763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antinociceptive activity of Muntingia calabura aqueous extract and the involvement of L-arginine/nitric oxide/cyclic guanosine monophosphate pathway in its observed activity in mice.
    Zakaria ZA; Sulaiman MR; Jais AM; Somchit MN; Jayaraman KV; Balakhrisnan G; Abdullah FC
    Fundam Clin Pharmacol; 2006 Aug; 20(4):365-72. PubMed ID: 16867020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide synthase inhibitors enhance the antinociceptive effects of oxotremorine in mice.
    Pavone F; Capone F; Populin R; Przewłocka B
    Pol J Pharmacol; 1997; 49(1):31-6. PubMed ID: 9431549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenergic, serotonergic and cholinergic components of nicotinic antinociception in rats.
    Iwamoto ET; Marion L
    J Pharmacol Exp Ther; 1993 May; 265(2):777-89. PubMed ID: 8388459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.